CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$1.28+0.09 (+7.56%)
Close on Nov 13, 2026Market cap $22.51MP/E –Yield –
Cel Sci enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cel Sci's enterprise value was $16.51M on Nov 11, 2026, against $58.48M a year earlier. Over the last 5 years it ranged from $3.98M to $264.59M, with a median of $58.22M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $16.51M | -57.8% |
| 2025 | Dec 31, 2025 | $39.17M | +88.5% |
| 2024 | Dec 31, 2024 | $20.78M | -83.4% |
| 2023 | Dec 29, 2023 | $124.86M | +57.2% |
| 2022 | Dec 30, 2022 | $79.44M | -70.0% |
| 2021 | Dec 31, 2021 | $264.59M | -39.3% |
| 2020 | Dec 31, 2020 | $436.13M | +38.9% |
| 2019 | Dec 31, 2019 | $313.96M | +347.5% |
| 2018 | Dec 31, 2018 | $70.16M | +248.6% |
| 2017 | Dec 29, 2017 | $20.13M | +151.1% |
| 2016 | Dec 30, 2016 | $8.02M | -77.6% |
| 2015 | Dec 31, 2015 | $35.81M | -8.1% |
| 2014 | Dec 31, 2014 | $38.99M | +113.5% |
| 2013 | Dec 31, 2013 | $18.26M | -73.8% |
| 2012 | Dec 31, 2012 | $69.80M | +20.3% |
| 2011 | Dec 30, 2011 | $58.01M | -59.0% |
| 2010 | Dec 31, 2010 | $141.43M | +63.3% |
| 2009 | Dec 31, 2009 | $86.62M | – |
See a number that looks wrong?